Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...
Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...
California lawmakers are fighting over a bill that would study replacing the gas tax with a road use charge. Republicans call it a sneaky plan to raise taxes. However, the ...
The vast majority of organ donations once came from people who were brain-dead. But last year about half of the deceased organ donations came from people who died when their ...
Are you into games that challenge you both physically and mentally at the same time? If so, Activate — an international live-action gaming brand offering high-energy, team-based experiences built ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results